Quercetin-loaded poly (lactic-co-glycolic acid)-d-α-tocopheryl polyethylene glycol 1000 succinate nanoparticles for the targeted treatment of liver cancer

References

• Abraham MH, Acree WE. Jr (2014). On the solubility of quercetin. J Mol Liq 197:157–9
   Web of Science ®Google Scholar
• Altekruse SF, McGlynn KA, Reichman ME. (2009). Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005. J Clin Oncol 27:1485–91
   PubMed Web of Science ®Google Scholar
• Bao X, Gao M, Xu H, et al. (2015). A novel oleanolic acid-loaded PLGA-TPGS nanoparticle for liver cancer treatment. Drug Dev Ind Pharm 41:1193–203
   PubMed Web of Science ®Google Scholar
• Chatterjee R, Mitra A. (2015). An overview of effective therapies and recent advances in biomarkers for chronic liver diseases and associated liver cancer. Int Immunopharmacol 24:335–45
   PubMed Web of Science ®Google Scholar
• Chen Z, Liu D, Wang J, et al. (2014). Development of nanoparticles-in-microparticles system for improved local retention after intra-articular injection. Drug Deliv 21:342–50
   PubMed Web of Science ®Google Scholar
• Chen HB, Zheng Y, Tian G, et al. (2011). Oral delivery of DMAB-modified docetaxel-loaded PLGA-TPGS nanoparticles for cancer chemotherapy. Nanoscale Res Lett 6:4
   PubMed Web of Science ®Google Scholar
• Chen C, Zhou J, Ji C. (2010). Quercetin: a potential drug to reverse multidrug resistance. Life Sci 87:333–8
   PubMed Web of Science ®Google Scholar
• Collnot EM, Baldes C, Wempe MF, et al. (2007). Mechanism of inhibition of P-glycoprotein mediated efflux by vitamin E TPGS: influence on ATPase activity and membrane fluidity. Mol Pharm 4:465–74
   PubMed Web of Science ®Google Scholar
• Dajas F. (2012). Life or death: neuroprotective and anticancer effects of quercetin. J Ethnopharmacol 143:383–96
   PubMed Web of Science ®Google Scholar
• Fox ME, Szoka FC, Frechet JMJ. (2009). Soluble polymer carriers for the treatment of cancer: the importance of molecular architecture. Acc Chem Res 42:1141–51
   PubMed Web of Science ®Google Scholar
• Gao M, Xu H, Zhang CH, et al. (2014). Preparation and characterization of curcumin thermosensitive hydrogels for intratumoral injection treatment. Drug Dev Ind Pharm 40:1557–64
   PubMed Web of Science ®Google Scholar
• Guo Y, Luo J, Tan S, et al. (2013). The applications of vitamin E TPGS in drug delivery. Eur J Pharm Sci 49:175–86
   PubMed Web of Science ®Google Scholar
• Hansen RK, Oesterreich S, Lemieux P, et al. (1997). Quercetin inhibits heat shock protein induction but not heat shock factor DNA-binding in human breast carcinoma cells. Biochem Biophys Res Commun 239:851–6
   PubMed Web of Science ®Google Scholar
• Huang YT, Hwang JJ, Lee PP, et al. (1999). Effects of luteolin and quercetin, inhibitors of tyrosine kinase, on cell growth and metastasis-associated properties in A431 cells overexpressing epidermal growth factor receptor. Br J Pharmacol 128:999–1010
   PubMed Web of Science ®Google Scholar
• Jain RA. (2000). The manufacturing techniques of various drug loaded biodegradable poly (lactide-co-glycolide) (PLGA) devices. Biomaterials 21:2475–90
   PubMed Web of Science ®Google Scholar
• Kang TB, Liang NC. (1997). Studies on the inhibitory effects of quercetin on the growth of HL-60 leukemia cells. Biochem Pharmacol 54:1013–18
   PubMed Web of Science ®Google Scholar
• Kim WK, Bang MH, Kim ES, et al. (2005). Quercetin decreases the expression of ErbB2 and ErbB3 proteins in HT-29 human colon cancer cells. J Nutr Biochem 16:155–62
   PubMed Web of Science ®Google Scholar
• Knowles LM, Zigrossi DA, Tauber RA, et al. (2000). Flavonoids suppress androgen-independent human prostate tumor proliferation. Nutr Cancer 38:116–22
   PubMed Web of Science ®Google Scholar
• Kreuter J, Shamenkov D, Petrov V, et al. (2002). Apolipoprotein-mediated transport of nanoparticle-bound drugs across the blood-brain barrier. J Drug Target 10:317–25
   PubMed Web of Science ®Google Scholar
• Ma Y, Zheng Y, Liu K, et al. (2010). Nanoparticles of poly(lactide-co-glycolide)-d-a-tocopheryl polyethylene glycol 1000 succinate random copolymer for cancer treatment. Nanoscale Res Lett 5:1161–9
   PubMed Web of Science ®Google Scholar
• Makadia HK, Siegel SJ. (2011). Poly lactic-co-glycolic acid (PLGA) as biodegradable controlled drug delivery carrier. Polymers (Basel) 3:1377–97
   PubMed Web of Science ®Google Scholar
• Maurya AK, Vinayak M. (2015). Quercetin regresses Dalton's lymphoma growth via suppression of PI3K/AKT signaling leading to upregulation of p53 and decrease in energy metabolism. Nutr Cancer 67:354–63
   PubMed Web of Science ®Google Scholar
• Morise Z, Kawabe N, Tomishige H, et al. (2014a). Recent advances in the surgical treatment of hepatocellular carcinoma. World J Gastroenterol 20:14381–92
   PubMed Web of Science ®Google Scholar
• Morise Z, Kawabe N, Tomishige H, et al. (2014b). Recent advances in liver resection for hepatocellular carcinoma. Front Surg 1:1–8
   Google Scholar
• Mukherjee A, Khuda-Bukhsh AR. (2015). Quercetin down-regulates IL-6/STAT-3 signals to induce mitochondrial-mediated apoptosis in a nonsmall-cell lung-cancer cell line, A549. J Pharmacopuncture 18:19–26
   PubMed Web of Science ®Google Scholar
• Ngamwongsatit P, Banada PP, Panbangred W, Bhunia AK. (2008). WST-1-based cell cytotoxicity assay as a substitute for MTT-based assay for rapid detection of toxigenic bacillus species using CHO cell line. J Microbiol Methods 73:211–15
   PubMed Web of Science ®Google Scholar
• Padhya KT, Marrero JA, Singal AG. (2013). Recent advances in the treatment of hepatocellular carcinoma. Curr Opin Gastroenterol 29:285–92
   PubMed Web of Science ®Google Scholar
• Panyam J, Sahoo SK, Prabha S, et al. (2003). Fluorescence and electron microscopy probes for cellular and tissue uptake of poly(D,L-lactide-co-glycolide) nanoparticles. Int J Pharm 262:1–11
   PubMed Web of Science ®Google Scholar
• Russo GL, Russo M, Spagnuolo C, et al. (2014). Quercetin: a pleiotropic kinase inhibitor against cancer. Cancer Treat Res 159:185–205
   PubMedGoogle Scholar
• Singh G, Pai RS. (2014). Pharmacokinetics and in vivo biodistribution of optimized PLGA nanoparticulate drug delivery system for controlled release of emtricitabine. Drug Deliv 21:627–35
   PubMed Web of Science ®Google Scholar
• Spencer DS, Puranik AS, Peppas NA. (2015). Intelligent nanoparticles for advanced drug delivery in cancer treatment. Curr Opin Chem Eng 7:84–92
   PubMed Web of Science ®Google Scholar
• Tan J, Wang B, Zhu L. (2009). Regulation of survivin and Bcl-2 in HepG2 cell apoptosis induced by quercetin. Chem Biodivers 6:1101–10
   PubMed Web of Science ®Google Scholar
• Truong NP, Whittaker MR, Mak CW, Davis TP. (2015). The importance of nanoparticle shape in cancer drug delivery. Expert Opin Drug Deliv 12:129–42
   PubMed Web of Science ®Google Scholar
• Yadav AK, Agarwal A, Rai G, et al. (2010). Development and characterization of hyaluronic acid decorated PLGA nanoparticles for delivery of 5-fluorouracil. Drug Deliv 17:561–72
   PubMed Web of Science ®Google Scholar
• Zimmer A, Kreuter J. (1995). Microspheres and nanoparticles used in ocular delivery systems. Adv Drug Deliv Rev 16:61–73
   Web of Science ®Google Scholar